Ajooni Biotech Limited, in a board meeting held on May 21, 2026, officially approved the appointment of M/s. N. Kumar & Company, Chartered Accountants, Punjab, as the Internal Auditors of the company for the financial year 2025-26.

Ajooni Biotech Limited, established in 2010 and headquartered in Mohali, Punjab, is a prominent player in the Indian animal healthcare and nutrition sector. The company specializes in the manufacturing and distribution of a wide range of animal feed and health supplements, including mineral mixtures, calcium supplements, liver tonics, and various cattle feed products designed to improve livestock productivity and milk yield. Recognized as India’s first GMP-certified cattle feed company, Ajooni operates a manufacturing facility in Punjab and serves a diverse client base that includes major dairy cooperatives and private poultry farms. The company, which is listed on the National Stock Exchange (NSE), has been actively expanding its production capacity, recently commissioning a new state-of-the-art facility in Khanna, Punjab, to support its growth objectives and market reach.

In 2025, Ajooni Biotech focused on strengthening its operational footprint and market position. The company successfully operationalized its new production facility in Khanna, which significantly enhanced its annual production capacity. Furthermore, Ajooni secured several notable orders, including a significant contract worth ₹25 crore from a leading dairy cooperative and another worth ₹4.80 crore for the supply of scientifically formulated cattle feed. These developments, alongside the appointment of over 300 dealers and distributors, underscored the company’s commitment to expanding its B2C presence and optimizing its supply chain efficiency throughout the year.

The company’s financial performance demonstrated growth during the latter half of 2025. For the quarter ended December 2025, the company reported a standalone net profit of ₹1.65 crore, representing a 126.03% increase compared to the ₹0.73 crore profit recorded in the quarter ended December 2024. Revenue for the same period stood at ₹58.75 crore, a 72.64% increase from ₹34.03 crore in the corresponding quarter of the previous year. While the company has shown positive growth in its quarterly results, specific details regarding famous individual investors are not prominently highlighted in current public records.